Main > ONCOLOGY (**) > Breast Cancer *** > Treatment * > Co: SE. O. DoxoRubicin.HCl> > >NanoParticle Vitamin A Formulation

---

>NanoParticle Vitamin A Formulation's subsections
(*) RU Approval Date: 2017. 08.08
Company
Company Marketing By:
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2017. 08.08
PR Web-Site
TradeMark

>NanoParticle Vitamin A Formulation's products
This section has no products